Dexcom Inc (NASDAQ:DXCM)
| 288.15 Delayed Data As of May 24 |  -35.79 / -11.05%Today’s Change | 282.93 Today|||52-Week Range 659.45 | -46.34% Year-to-Date |
Latest DXCM News | Press Releases
| Why DexCom Is Down More Than 11% on Tuesday May 24 / MotleyFool.com - Paid Partner Content | Are Options Traders Betting on a Big Move in DexCom (DXCM) Stock? May 19 / Zacks.com - Paid Partner Content |
| Here's Why You Should Hold on to DexCom (DXCM) Stock Now May 19 / Zacks.com - Paid Partner Content | 2 Unstoppable Growth Stocks to Buy in 2022 and Beyond May 11 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 323.92 |
| Today’s open | 296.33 |
| Day’s range | 282.93 - 306.48 |
| Volume | 2,121,267 |
| Average volume (3 months) | 845,165 |
| Market cap | $31.5B |
Data as of 4:00pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | -69.40% |
| Earnings growth (this year) | +24.40% |
| Earnings growth (next 5 years) | +42.75% |
| Revenue growth (last year) | +27.08% |
| P/E ratio | 150.1 |
| Price/Sales | 21.95 |
| Price/Book | 13.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BAXBaxter International... | +0.05 | +0.07% |
| ZBHZimmer Biomet Holdin... | +0.07 | +0.06% |
| WSTWest Pharmaceutical ... | +0.01 | +0.00% |
| SAUHFStraumann Holding AG | -1.75 | -1.47% |
Data as of 4:24pm ET, 05/24/2022
Financials
| Next reporting date | August 2, 2022 |
| EPS forecast (this quarter) | $0.75 |
| Annual revenue (last year) | $2.4B |
| Annual profit (last year) | $154.7M |
| Net profit margin | 6.32% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
